Literature DB >> 11355692

Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase.

Y K Chung1, H J Heo, E K Kim, H K Kim, T L Huh, Y Lim, S K Kim, D H Shin.   

Abstract

We screened 139 herbal spices in search of the acetylcholinesterase (AChE) inhibitor from natural resources. AChE inhibitors, which enhance cholinergic transmission by reducing the enzymatic degradation of acetylcholine, are the only source of compound currently approved for the treatment of Alzheimer's Disease (AD). Among these herbs, edible plants and spices, the ethanol extract from Origanum majorana L. showed the highest inhibitory effect on AChE in vitro. By sequential fractionation of Origanum majorana L. the active component was finally identified as ursolic acid (3 beta-Hydroxyurs-12-en-28-oic acid). The ursolic acid of Origanum majorana L. inhibited AChE activity in a dose-dependent and competitive/non-competitive type. The Ki value (representing the affinity of the enzyme and inhibitor) of Origanum majorana L. ursolic acid was 6 pM, and that of tacrine was 0.4 nM. The concentration required for 50% enzyme inhibition of the active component (IC50 value) was 7.5 nM, and that of tacrine was 1 nM. This study demonstrated that the ursolic acid of Origanum majorana L. appeared to be a potent AChE inhibitor in Alzheimer's Disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355692

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  14 in total

Review 1.  Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia.

Authors:  Ying Wang; Lu-qi Huang; Xi-can Tang; Hai-yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

2.  Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma.

Authors:  Mark Moss; Lorraine Oliver
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

Review 3.  Neuroprotection by spice-derived nutraceuticals: you are what you eat!

Authors:  Ramaswamy Kannappan; Subash Chandra Gupta; Ji Hye Kim; Simone Reuter; Bharat Bhushan Aggarwal
Journal:  Mol Neurobiol       Date:  2011-03-01       Impact factor: 5.590

Review 4.  Sweet Marjoram: A Review of Ethnopharmacology, Phytochemistry, and Biological Activities.

Authors:  Fatemeh Bina; Roja Rahimi
Journal:  J Evid Based Complementary Altern Med       Date:  2016-05-26

Review 5.  Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.

Authors:  Ana B Ramos-Hryb; Francis L Pazini; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

6.  Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.

Authors:  Andreia Gomes; Sofia Fortalezas; Rui Pimpão; Inês Figueira; João Maroco; Carlos Aguiar; Ricardo B Ferreira; Célia Miguel; Cláudia N Santos
Journal:  Antioxidants (Basel)       Date:  2013-10-28

7.  Antioxidant and Anticholinesterase Activities of Extracts and Phytochemicals of Syzygium antisepticum Leaves.

Authors:  Supachoke Mangmool; Issaree Kunpukpong; Worawan Kitphati; Natthinee Anantachoke
Journal:  Molecules       Date:  2021-05-30       Impact factor: 4.411

Review 8.  Cholinesterase inhibitors from botanicals.

Authors:  Faiyaz Ahmed; Raza Murad Ghalib; P Sasikala; K K Mueen Ahmed
Journal:  Pharmacogn Rev       Date:  2013-07

9.  Screening of siddha medicinal plants for its in-vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity.

Authors:  Madhuri Kadiyala; Sivasankaran Ponnusankar; Kannan Elango
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

10.  Ethanol Extract of Oldenlandia diffusa Herba Attenuates Scopolamine-Induced Cognitive Impairments in Mice via Activation of BDNF, P-CREB and Inhibition of Acetylcholinesterase.

Authors:  Jung Eun Lee; Hyo-Sook Song; Moon Nyeo Park; Sung-Hoon Kim; Bum-Sang Shim; Bonglee Kim
Journal:  Int J Mol Sci       Date:  2018-01-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.